191 related articles for article (PubMed ID: 36335829)
1. Biased agonists differentially modulate the receptor conformation ensembles in Angiotensin II type 1 receptor.
Nivedha AK; Lee S; Vaidehi N
J Mol Graph Model; 2023 Jan; 118():108365. PubMed ID: 36335829
[TBL] [Abstract][Full Text] [Related]
2. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
[TBL] [Abstract][Full Text] [Related]
3. Biased agonism of the angiotensin II type 1 receptor.
Godin CM; Ferguson SS
Mini Rev Med Chem; 2012 Aug; 12(9):812-6. PubMed ID: 22681254
[TBL] [Abstract][Full Text] [Related]
4. Nanobody-Mediated Dualsteric Engagement of the Angiotensin Receptor Broadens Biased Ligand Pharmacology.
Braga Emidio N; Small BM; Keller AR; Cheloha RW; Wingler LM
Mol Pharmacol; 2024 Feb; 105(3):260-271. PubMed ID: 38164609
[TBL] [Abstract][Full Text] [Related]
5. Loss of biased signaling at a G protein-coupled receptor in overexpressed systems.
Li A; Liu S; Huang R; Ahn S; Lefkowitz RJ
PLoS One; 2023; 18(3):e0283477. PubMed ID: 36961836
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR.
Wingler LM; Skiba MA; McMahon C; Staus DP; Kleinhenz ALW; Suomivuori CM; Latorraca NR; Dror RO; Lefkowitz RJ; Kruse AC
Science; 2020 Feb; 367(6480):888-892. PubMed ID: 32079768
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin Analogs with Divergent Bias Stabilize Distinct Receptor Conformations.
Wingler LM; Elgeti M; Hilger D; Latorraca NR; Lerch MT; Staus DP; Dror RO; Kobilka BK; Hubbell WL; Lefkowitz RJ
Cell; 2019 Jan; 176(3):468-478.e11. PubMed ID: 30639099
[TBL] [Abstract][Full Text] [Related]
8. Mechanoactivation of the angiotensin II type 1 receptor induces β-arrestin-biased signaling through Gα
Wang J; Hanada K; Gareri C; Rockman HA
J Cell Biochem; 2018 Apr; 119(4):3586-3597. PubMed ID: 29231251
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II cyclic analogs as tools to investigate AT
St-Pierre D; Cabana J; Holleran BJ; Besserer-Offroy É; Escher E; Guillemette G; Lavigne P; Leduc R
Biochem Pharmacol; 2018 Aug; 154():104-117. PubMed ID: 29684376
[TBL] [Abstract][Full Text] [Related]
10. Single-molecule force spectroscopy study of interactions between angiotensin II type 1 receptor and different biased ligands in living cells.
Li W; Xu J; Kou X; Zhao R; Zhou W; Fang X
Anal Bioanal Chem; 2018 May; 410(14):3275-3284. PubMed ID: 29492619
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin type 1A receptor regulates β-arrestin binding of the β
Tóth AD; Gyombolai P; Szalai B; Várnai P; Turu G; Hunyady L
Mol Cell Endocrinol; 2017 Feb; 442():113-124. PubMed ID: 27908837
[TBL] [Abstract][Full Text] [Related]
12. Heterotrimeric Gq proteins act as a switch for GRK5/6 selectivity underlying β-arrestin transducer bias.
Kawakami K; Yanagawa M; Hiratsuka S; Yoshida M; Ono Y; Hiroshima M; Ueda M; Aoki J; Sako Y; Inoue A
Nat Commun; 2022 Jan; 13(1):487. PubMed ID: 35078997
[TBL] [Abstract][Full Text] [Related]
13. Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression.
Ferraino KE; Cora N; Pollard CM; Sizova A; Maning J; Lymperopoulos A
Cell Signal; 2021 Jun; 82():109967. PubMed ID: 33640432
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.
Cao Y; Kumar S; Namkung Y; Gagnon L; Cho A; Laporte SA
J Biol Chem; 2020 Sep; 295(38):13169-13180. PubMed ID: 32703898
[TBL] [Abstract][Full Text] [Related]
15. Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.
Cabana J; Holleran B; Leduc R; Escher E; Guillemette G; Lavigne P
J Biol Chem; 2015 Jun; 290(25):15835-15854. PubMed ID: 25934394
[TBL] [Abstract][Full Text] [Related]
16. Unraveling allostery within the angiotensin II type 1 receptor for Gα
Cao Y; van der Velden WJC; Namkung Y; Nivedha AK; Cho A; Sedki D; Holleran B; Lee N; Leduc R; Muk S; Le K; Bhattacharya S; Vaidehi N; Laporte SA
Sci Signal; 2023 Aug; 16(797):eadf2173. PubMed ID: 37552769
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signaling.
Lymperopoulos A; Borges JI; Carbone AM; Cora N; Sizova A
Pharmacol Res; 2021 Dec; 174():105943. PubMed ID: 34662735
[TBL] [Abstract][Full Text] [Related]
18. Divergent transducer-specific molecular efficacies generate biased agonism at a G protein-coupled receptor (GPCR).
Strachan RT; Sun JP; Rominger DH; Violin JD; Ahn S; Rojas Bie Thomsen A; Zhu X; Kleist A; Costa T; Lefkowitz RJ
J Biol Chem; 2014 May; 289(20):14211-24. PubMed ID: 24668815
[TBL] [Abstract][Full Text] [Related]
19. Genetic code expansion and photocross-linking identify different β-arrestin binding modes to the angiotensin II type 1 receptor.
Gagnon L; Cao Y; Cho A; Sedki D; Huber T; Sakmar TP; Laporte SA
J Biol Chem; 2019 Nov; 294(46):17409-17420. PubMed ID: 31530642
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanisms of Diverse Activation Stimulated by Different Biased Agonists for the β2-Adrenergic Receptor.
Chen J; Liu J; Yuan Y; Chen X; Zhang F; Pu X
J Chem Inf Model; 2022 Nov; 62(21):5175-5192. PubMed ID: 34802238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
